In the age of artificial intelligence are MDs being taught enough to capitalise on this emerging technological potential?

BCIs are best understood as constrained medical technologies rather than general-purpose enhancement tools… at least for the foreseeable future.

As I found this year, successful Australian medtech startups follow three key pillars: being science-first, hiring interdisciplinary staff and and carefully balancing product breadth with depth.